BD GeneOhm(TM) MRSA Assay Part Of Largest U.S. Study Using Universal Active Surveillance To Significantly Reduce MRSA Infection Rates

BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced that a new study, “Universal Surveillance for Methicillin-Resistant Staphylococcus aureus in 3 Affiliated Hospitals,” published in Annals of Internal Medicine, demonstrates that universal surveillance o

More: continued here

Filed under: MRSA / Drug Resistance on April 2nd, 2008